14 April 2017 - Staff at one of the world’s leading drug companies discussed destroying supplies of lifesaving cancer medicines in a battle to impose massive price rises across Europe.
The proposal was raised at Aspen Pharmacare during a dispute with the Spanish health service in 2014 over attempts to increase the price of the medicines by up to 4000%.
The company, which runs its European operations from Dublin, began a continent-wide effort to drive up the price of five cancer medicines after buying the rights from the British company GSK.